Clinical Trial Update: Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating topical interferon alfa-2b in combination with mitomycin C for conjunctival intraepithelial neoplasia and corneal intraepithel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conjunctival Intraepithelial Neoplasia
• Corneal Intraepithelial Neoplasia

Drugs mentioned

• Mitomycin-C (mitomycin C)
• Topical Interferon alfa-2b (Interferon alfa-2b)

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Conjunctival Intraepithelial Neoplasia, Corneal Intraepithelial Neoplasia | Phase 4 | Status: COMPLETED